Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-13 5:54 pm Sale | 13G | IVERIC bio, Inc. ISEE | Vivo Capital IX LLC | 0 0% | -5,202,348![]() (Position Closed) | View |
2023-02-13 5:52 pm Sale | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX LLC | 2,262,200 8.5% | -725,131![]() (-24.27%) | View |
2023-02-13 5:51 pm Unchanged | 13G | Genetron Holdings Limited GTH | Vivo Capital IX LLC | 28,574,300 6.3% | 0 (Unchanged) | View |
2023-02-13 5:48 pm Sale | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX LLC | 3,761,947 3.1% | -5,647,104![]() (-60.02%) | View |
2023-02-13 5:44 pm Purchase | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Capital IX LLC | 772,068 2.3% | 772,068![]() (New Position) | View |
2022-07-05 5:06 pm Sale | 13G | Sierra Oncology Inc. SRRA | Vivo Capital IX LLC | 0 0% | -2,735,852![]() (Position Closed) | View |
2022-02-11 5:27 pm Sale | 13G | Larimar Therapeutics, Inc. LRMR | Vivo Capital IX LLC | 326,888 1.8% | -326,891![]() (-50.00%) | View |
2022-02-11 5:26 pm Purchase | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX LLC | 9,409,051 7.8% | 448,755![]() (+5.01%) | View |
2022-02-11 5:25 pm Purchase | 13G | IVERIC bio, Inc. ISEE | Vivo Capital IX LLC | 5,202,348 4.5% | 324,300![]() (+6.65%) | View |
2022-02-11 5:23 pm Purchase | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX LLC | 624,902 1.4% | 624,902![]() (New Position) | View |
2022-02-11 5:22 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Vivo Capital IX LLC | 2,735,852 14.7% | 799,999![]() (+41.33%) | View |
2022-02-11 5:21 pm Sale | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX LLC | 2,987,331 14.4% | -257,704![]() (-7.94%) | View |
2021-11-12 4:30 pm Purchase | 13G | IO Biotech, Inc. IOBT | Vivo Capital IX LLC | 3,015,545 10.5% | 3,015,545![]() (New Position) | View |
2021-11-05 5:00 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Vivo Capital IX LLC | 1,935,853 14.8% | 480,277![]() (+33.00%) | View |
2021-07-23 4:30 pm Purchase | 13G | Sera Prognostics, Inc. SERA | Vivo Capital IX LLC | 1,856,011 6.4% | 1,856,011![]() (New Position) | View |
2021-04-01 4:33 pm Purchase | 13G | Instil Bio, Inc. TIL | Vivo Capital IX LLC | 12,486,787 9.7% | 12,486,787![]() (New Position) | View |
2021-02-16 4:30 pm Sale | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX LLC | 8,960,296 8.168% | -21,635,328![]() (-70.71%) | View |
2021-02-12 4:30 pm Sale | 13G | Chinook Therapeutics, Inc. KDNY | Vivo Capital IX LLC | 987,624 2.3% | -3,197,152![]() (-76.40%) | View |
2021-02-12 4:30 pm Sale | 13G | Matinas BioPharma Holdings, Inc. MTNB | Vivo Capital IX LLC | 5,274,638 2.6% | -5,002,825![]() (-48.68%) | View |
2021-02-12 4:30 pm Purchase | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX LLC | 1,562,603 4.7% | 152,089![]() (+10.78%) | View |